Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

173.82 +0.49 (+0.28%)
Official Closing Price Updated: 7:00 PM EDT, Aug 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,256,797
Open 173.40
Bid (Size) 173.82 (1)
Ask (Size) 175.00 (2)
Prev. Close 173.33
Today's Range 173.05 - 174.60
52wk Range 140.68 - 174.60
Shares Outstanding 2,628,679,824
Dividend Yield 2.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Specter of Stagflation: Trump's Tariffs Cast a Long Shadow Over the U.S. Economy
Economists and investors are increasingly sounding the alarm over the growing risk of "stagflation," a perilous economic phenomenon characterized by high inflation coupled with stagnant economic... 
Via MarketMinute
Topics Economy Government Supply Chain
Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva
Novartis' ianalumab showed significant disease activity improvement in two Phase 3 Sjögren's trials, supporting plans for global health authority filings. 
Via Benzinga

Performance

YTD
+20.7%
+20.7%
1 Month
+10.8%
+10.8%
3 Month
+12.8%
+12.8%
6 Month
+12.7%
+12.7%
1 Year
+8.7%
+8.7%

More News

Read More
3 Big Dividend Plays With Strong Earnings to Back Them
Via MarketBeat
Topics Earnings
Worried About a Fading Rally? Consider These 3 Dividend Stocks
Via MarketBeat
Topics Artificial Intelligence Economy
5 Dividend Stocks to Hold for the Next 5 Years
Via The Motley Fool
3 Stocks Retirees Should Absolutely Love
Via The Motley Fool
Topics Economy Retirement
Is the Vanguard Value ETF the Simplest Way to Consistently Collect More Passive Income Than the S&P 500?
Via The Motley Fool
Topics ETFs Regulatory Compliance Stocks
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
Via Benzinga
U.S. Labor Market Shows Mixed Signals: Unemployment Claims Tick Up, Job Growth Slows
Via MarketMinute
Topics Bonds Economy
Political Tremors Rattle Markets: The Profound Impact of U.S. Elections and Tariff Shocks
Via MarketMinute
Topics Economy Government Stocks
U.S. Economy Navigates Choppy Waters: Weak Payrolls, Labor Slowdown, and Persistent Inflation Reshape Market Outlook
Via MarketMinute
Topics Earnings Economy World Trade
Stagflation Fears Resurface: Economic Data Signals Market Caution
Via MarketMinute
Topics Bonds Economy Government
Stagflation Specter Haunts Markets as Economic Data Disappoints
Via MarketMinute
Topics Economy Stocks World Trade
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Via Benzinga
Topics Lawsuit
Wall Street Giants Warn of Impending Stock Market Pullback: Is a Correction on the Horizon?
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Beyond Jobs: Key Economic Indicators Investors Are Watching for Market Health Clues
Via MarketMinute
Topics Economy Supply Chain World Trade
Are Stocks Overheating? Analysts Debate Market Valuations Amidst Record Highs
Via MarketMinute
Topics Bonds Economy
Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock for Reliable Income Investors
Via Chartmill
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
From AI To Emerging Markets: How 6 Pros Would Allocate $10K In Today's Market
Via Benzinga
Topics Artificial Intelligence
The 3 Things That Matter for Johnson & Johnson Now
Via The Motley Fool
Topics Bankruptcy Intellectual Property Lawsuit
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Microsoft, Meta Stocks Add $440 Billion In A Day—Nearly Matching Netflix's Entire $503 Billion Market Cap
Via Benzinga
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 173.82
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 08/11/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 456.92B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 457B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.